Literature DB >> 8579098

Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

R Vidal1, F Garzuly, H Budka, M Lalowski, R P Linke, F Brittig, B Frangione, T Wisniewski.   

Abstract

We describe a novel transthyretin mutation at codon 18 where Asp is replaced by Gly (D18G) in a Hungarian kindred. This mutation is associated with meningocerebrovascular amyloidosis, producing dementia, ataxia, and spasticity. Fifty different transthyretin mutations are related to amyloid deposition, typically producing a peripheral neuropathy or cardiac dysfunction. These symptoms are absent in this family. Up to now, amyloid-beta (A beta), cystatin C, and prion proteins have been known to be deposited as amyloid in the brain, leading to stroke or dementia. With this report we establish that transthyretin amyloid deposition can also produce central nervous system dysfunction as the major clinical symptom.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8579098      PMCID: PMC1861701     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

Review 2.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Cloning and sequence analysis of cDNA for human prealbumin.

Authors:  S Mita; S Maeda; K Shimada; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

4.  Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding.

Authors:  C C Blake; M J Geisow; I D Swan; C Rerat; B Rerat
Journal:  J Mol Biol       Date:  1974-09-05       Impact factor: 5.469

Review 5.  Transthyretin mutations in health and disease.

Authors:  M J Saraiva
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

6.  Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs.

Authors:  H Furuya; K Yoshioka; H Sasaki; Y Sakaki; M Nakazato; H Matsuo; A Nakadai; S Ikeda; N Yanagisawa
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

Authors:  J Ghiso; O Jensson; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 8.  Alzheimer's disease and soluble A beta.

Authors:  T Wisniewski; J Ghiso; B Frangione
Journal:  Neurobiol Aging       Date:  1994 Mar-Apr       Impact factor: 4.673

9.  Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin.

Authors:  M Pras; F Prelli; E C Franklin; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17.

Authors:  R B Petersen; M Tabaton; S G Chen; L Monari; S L Richardson; T Lynch; V Manetto; D J Lanska; W R Markesbery; T ] Lynches T [corrected to Lynch
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  19 in total

1.  Presenilin-1 is associated with Alzheimer's disease amyloid.

Authors:  T Wisniewski; W K Dowjat; B Permanne; J Palha; A Kumar; G Gallo; B Frangione
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; T A Newman; M Hutchings; Y M Kuo; A E Roher
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  Cellular clearance of circulating transthyretin decreases cell-nonautonomous proteotoxicity in Caenorhabditis elegans.

Authors:  Kayalvizhi Madhivanan; Erin R Greiner; Miguel Alves-Ferreira; David Soriano-Castell; Nirvan Rouzbeh; Carlos A Aguirre; Johan F Paulsson; Justin Chapman; Xin Jiang; Felicia K Ooi; Carolina Lemos; Andrew Dillin; Veena Prahlad; Jeffery W Kelly; Sandra E Encalada
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

4.  Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.

Authors:  Octavio M Pontes-Neto; Eitan Auriel; Steven M Greenberg
Journal:  Eur Neurol Rev       Date:  2012

Review 5.  Leptomeningeal amyloid and variant transthyretins.

Authors:  M D Benson
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

6.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

Authors:  R Vidal; T Revesz; A Rostagno; E Kim; J L Holton; T Bek; M Bojsen-Møller; H Braendgaard; G Plant; J Ghiso; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Familial prion protein mutants inhibit Hrd1-mediated retrotranslocation of misfolded proteins by depleting misfolded protein sensor BiP.

Authors:  Sarah L Peters; Marc-André Déry; Andrea C LeBlanc
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

Review 8.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

Review 9.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

Review 10.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.